New insider activity at Abbott Laboratories ( (ABT) ) has taken place on November 25, 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SVP Eric Shroff recently sold 1,586 shares of Abbott Laboratories stock, amounting to a total transaction value of $203,039.
Spark’s Take on ABT Stock
According to Spark, TipRanks’ AI Analyst, ABT is a Outperform.
Abbott Laboratories’ strong financial performance and positive earnings call are the most significant factors driving the stock score. The company’s robust growth in medical devices and international markets, along with effective cost management, supports a favorable outlook. Technical analysis and valuation provide a balanced view, with some caution due to market resistance and external challenges.
To see Spark’s full report on ABT stock, click here.
More about Abbott Laboratories
YTD Price Performance: 14.58%
Average Trading Volume: 6,164,761
Technical Sentiment Signal: Buy
Current Market Cap: $221.2B